Patients in the Dallas area are feeling the sticker shock of the end of the GLP-1 shortages. APC's S...

Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Patients in the Dallas area are feeling the sticker shock of the end of the GLP-1 shortages. APC's S...
APC, along with several other organizations, has been fighting hard to protect California firefighte...
Over the last few weeks, with the FDA declaring the end of the GLP-1 shortages, APC’s reporter hotli...
In "Zepbound copycats remain online despite FDA ban," it looks at ways some compounders are continui...
How will the new administration regulate weight-loss drugs? The truth is, we don't know yet. Forbes ...
We’re pretty happy with Newsday’s coverage of how patients taking GLP-1 drugs will be affected by th...
The Wall Street Journal is looking past the FDA’s official ending of the GLP-1 shortages and into th...
The Royal Society of Chemistry's Chemistry World has a terrific piece on the ending of the semagluti...
Self has a long, well-balanced article on not just the current state of GLP-1 compounding, but a bro...
News outlets are moving from writing about the fact that GLP-1 compounding is effectively ending, an...
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.